APA (7th ed.) Citation

A, C., D, A., M, C., F, S., E, S., R, C., . . . Group, O. B. O. T. C. L. C. C. S. (2022). Monoclonal Antibodies and Antivirals against SARS-CoV-2 Reduce the Risk of Long COVID: A Retrospective Propensity Score-Matched Case-Control Study. Biomedicines, 10(12), . https://doi.org/10.3390/biomedicines10123135

Chicago Style (17th ed.) Citation

A, Cimellaro, et al. "Monoclonal Antibodies and Antivirals Against SARS-CoV-2 Reduce the Risk of Long COVID: A Retrospective Propensity Score-Matched Case-Control Study." Biomedicines 10, no. 12 (2022). https://doi.org/10.3390/biomedicines10123135.

MLA (9th ed.) Citation

A, Cimellaro, et al. "Monoclonal Antibodies and Antivirals Against SARS-CoV-2 Reduce the Risk of Long COVID: A Retrospective Propensity Score-Matched Case-Control Study." Biomedicines, vol. 10, no. 12, 2022, https://doi.org/10.3390/biomedicines10123135.